Live Webinar: Advances in NASH Drugs & The Role of NITs

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Advances in NASH Drugs & The Role of NITs.

Join presenter Dr. Stephen Harrison, a Key Opinion Leader in NASH, to learn about the exciting progress of NASH drugs and non-invasive tests in addressing this emerging health crisis. Key points to be covered:

  • Current management and treatment regimens for NASH
  • Promising therapies on the horizon to manage and treat NASH
  • Advances in non-invasive tests for assessing and managing patients

Date & Time:

June 10, 2021, 8:30AM to 9:30AM PT

Register Now

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our e-newsletter.

Julia PinterMarketing Director

Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.